Xcell Biosciences, an instrumentation company focused on cell and gene therapy applications, has partnered with Thermo Fisher ...

Starton Therapeutics Inc., a clinical-stage biotechnology company, has entered into a collaboration agreement with Bend Bioscience.

Novo Nordisk has ended its partnership with Hims & Hers Health Inc., citing “deceptive marketing” and the selling of ...

Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK. The opening ceremony was ...

Cellular Origins has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform ...

Aversa Fentanyl combines Nutriband’s Aversa abuse-deterrent technology with Kindeva’s FDA-approved fentanyl patch.

PharmaLogic Holdings Corp., a CDMO, has completed its previously announced acquisition of a majority stake in Agilera Pharma.

Formation Bio’s subsidiary, Libertas Bio, has licensed gusacitinib, an oral dual JAK/SYK inhibitor, to Sanofi.

Harbour BioMed has partnered with Otsuka Pharmaceutical Co., Ltd. to advance BCMAxCD3 bispecific T-cell engagers for the ...

Ferring Pharmaceutical officially opened its new 12,000-square-foot gene therapy manufacturing facility located within its US ...

The extended plans include 26,000 square feet of drug substance manufacturing suites, laboratories, storage, dispensing, and warehousing.

Together, they will find partners for the development of the ‘RSH Olfactory Delivery Device,’ a dual nostril intranasal ...